Loading…
Role of Chlamydia in Multiple Sclerosis
Chlamydia and antibodies to them were detected by serological, molecular biological, and culture methods in the sera and cerebrospinal fluid of patients with multiple sclerosis and in the reference groups of subjects without neurological diseases. Correlations between the agent presence in the biolo...
Saved in:
Published in: | Bulletin of experimental biology and medicine 2015-09, Vol.159 (5), p.646-648 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c573t-ec3dcc90003d23f01bc802125d9ffc959f6ed103a97ffc763815656c94b16ea33 |
---|---|
cites | cdi_FETCH-LOGICAL-c573t-ec3dcc90003d23f01bc802125d9ffc959f6ed103a97ffc763815656c94b16ea33 |
container_end_page | 648 |
container_issue | 5 |
container_start_page | 646 |
container_title | Bulletin of experimental biology and medicine |
container_volume | 159 |
creator | Ivanova, M. V. Kolkova, N. I. Morgunova, E. Yu Pashko, Yu. P. Zigangirova, N. A. Zakharova, M. N. |
description | Chlamydia and antibodies to them were detected by serological, molecular biological, and culture methods in the sera and cerebrospinal fluid of patients with multiple sclerosis and in the reference groups of subjects without neurological diseases. Correlations between the agent presence in the biological fluids of patients and clinical characteristics of the disease were analyzed.
C. pneumoniae
were more incident in the biological liquids of patients with multiple sclerosis than in healthy volunteers. On the other hand, the incidence of the agent in the patients was not high and its presence did not correlate with the clinical manifestations.
C. trachomatis
was equally rare in the patients and volunteers. The studies indicated the existence of a group of patients infected by
C. pneumoniae
in the cohort of patients with multiple sclerosis, but the impact of this agent for the disease course remains unclear. |
doi_str_mv | 10.1007/s10517-015-3037-z |
format | article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1785232174</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A455405128</galeid><sourcerecordid>A455405128</sourcerecordid><originalsourceid>FETCH-LOGICAL-c573t-ec3dcc90003d23f01bc802125d9ffc959f6ed103a97ffc763815656c94b16ea33</originalsourceid><addsrcrecordid>eNqNkU1rHDEMhk1oaDZpf0AuZSGQ9DKp5c-ZY1j6BSmFfJyN12NnHTzj7XjmkPz6atm0bEoCxQcj6XklpJeQY6DnQKn-VIBK0BUFWXHKdfW4R2YgNa9qxuANmVGEKlHX9QE5LOV-E1IFb8kBU0LVlIkZObvKyc9zmC9WyXYPbbTz2M9_TGmMayxcu-SHXGJ5R_aDTcW_f_qPyO2XzzeLb9Xlz6_fFxeXlcO5Y-Udb51rcBJvGQ8Ulg7nAJNtE4JrZBOUb4Fy22iMteI1SCWVa8QSlLecH5GP277rIf-afBlNF4vzKdne56kY0LVknIEW_4EqAbzhoBA9-Qe9z9PQ4yJIac4kE2KHurPJm9iHPA7WbZqaCyGlwGOzGqnzFyh8re-iy70PEfPPBKc7gpW3aVyVnKYx5r48B2ELOjx5GXww6yF2dngwQM3GcLM13KDhZmO4eUTNh6fNpmXn27-KPw4jwLZAwVJ_54ed1V_t-hvRIrBI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1773252446</pqid></control><display><type>article</type><title>Role of Chlamydia in Multiple Sclerosis</title><source>Springer Nature</source><creator>Ivanova, M. V. ; Kolkova, N. I. ; Morgunova, E. Yu ; Pashko, Yu. P. ; Zigangirova, N. A. ; Zakharova, M. N.</creator><creatorcontrib>Ivanova, M. V. ; Kolkova, N. I. ; Morgunova, E. Yu ; Pashko, Yu. P. ; Zigangirova, N. A. ; Zakharova, M. N.</creatorcontrib><description>Chlamydia and antibodies to them were detected by serological, molecular biological, and culture methods in the sera and cerebrospinal fluid of patients with multiple sclerosis and in the reference groups of subjects without neurological diseases. Correlations between the agent presence in the biological fluids of patients and clinical characteristics of the disease were analyzed.
C. pneumoniae
were more incident in the biological liquids of patients with multiple sclerosis than in healthy volunteers. On the other hand, the incidence of the agent in the patients was not high and its presence did not correlate with the clinical manifestations.
C. trachomatis
was equally rare in the patients and volunteers. The studies indicated the existence of a group of patients infected by
C. pneumoniae
in the cohort of patients with multiple sclerosis, but the impact of this agent for the disease course remains unclear.</description><identifier>ISSN: 0007-4888</identifier><identifier>EISSN: 1573-8221</identifier><identifier>DOI: 10.1007/s10517-015-3037-z</identifier><identifier>PMID: 26468024</identifier><identifier>CODEN: BEXBAN</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adult ; Antibodies ; Antibodies, Bacterial - blood ; Antibodies, Bacterial - cerebrospinal fluid ; Bacterial Typing Techniques ; Biomedical and Life Sciences ; Biomedicine ; Case-Control Studies ; Cell Biology ; Chlamydia ; Chlamydia infections ; Chlamydia Infections - blood ; Chlamydia Infections - cerebrospinal fluid ; Chlamydia Infections - microbiology ; Chlamydia Infections - pathology ; Chlamydia trachomatis - isolation & purification ; Chlamydia trachomatis - physiology ; Chlamydophila pneumoniae ; Chlamydophila pneumoniae - isolation & purification ; Chlamydophila pneumoniae - physiology ; DNA, Bacterial - blood ; DNA, Bacterial - cerebrospinal fluid ; Female ; Humans ; Immunoglobulin A - blood ; Immunoglobulin A - cerebrospinal fluid ; Immunoglobulin G - blood ; Immunoglobulin G - cerebrospinal fluid ; Immunoglobulin M - blood ; Immunoglobulin M - cerebrospinal fluid ; Internal Medicine ; Laboratory Medicine ; Male ; Middle Aged ; Multiple sclerosis ; Multiple Sclerosis - blood ; Multiple Sclerosis - cerebrospinal fluid ; Multiple Sclerosis - microbiology ; Multiple Sclerosis - pathology ; Pathology ; Pneumonia ; Severity of Illness Index</subject><ispartof>Bulletin of experimental biology and medicine, 2015-09, Vol.159 (5), p.646-648</ispartof><rights>Springer Science+Business Media New York 2015</rights><rights>COPYRIGHT 2015 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c573t-ec3dcc90003d23f01bc802125d9ffc959f6ed103a97ffc763815656c94b16ea33</citedby><cites>FETCH-LOGICAL-c573t-ec3dcc90003d23f01bc802125d9ffc959f6ed103a97ffc763815656c94b16ea33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26468024$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ivanova, M. V.</creatorcontrib><creatorcontrib>Kolkova, N. I.</creatorcontrib><creatorcontrib>Morgunova, E. Yu</creatorcontrib><creatorcontrib>Pashko, Yu. P.</creatorcontrib><creatorcontrib>Zigangirova, N. A.</creatorcontrib><creatorcontrib>Zakharova, M. N.</creatorcontrib><title>Role of Chlamydia in Multiple Sclerosis</title><title>Bulletin of experimental biology and medicine</title><addtitle>Bull Exp Biol Med</addtitle><addtitle>Bull Exp Biol Med</addtitle><description>Chlamydia and antibodies to them were detected by serological, molecular biological, and culture methods in the sera and cerebrospinal fluid of patients with multiple sclerosis and in the reference groups of subjects without neurological diseases. Correlations between the agent presence in the biological fluids of patients and clinical characteristics of the disease were analyzed.
C. pneumoniae
were more incident in the biological liquids of patients with multiple sclerosis than in healthy volunteers. On the other hand, the incidence of the agent in the patients was not high and its presence did not correlate with the clinical manifestations.
C. trachomatis
was equally rare in the patients and volunteers. The studies indicated the existence of a group of patients infected by
C. pneumoniae
in the cohort of patients with multiple sclerosis, but the impact of this agent for the disease course remains unclear.</description><subject>Adult</subject><subject>Antibodies</subject><subject>Antibodies, Bacterial - blood</subject><subject>Antibodies, Bacterial - cerebrospinal fluid</subject><subject>Bacterial Typing Techniques</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Case-Control Studies</subject><subject>Cell Biology</subject><subject>Chlamydia</subject><subject>Chlamydia infections</subject><subject>Chlamydia Infections - blood</subject><subject>Chlamydia Infections - cerebrospinal fluid</subject><subject>Chlamydia Infections - microbiology</subject><subject>Chlamydia Infections - pathology</subject><subject>Chlamydia trachomatis - isolation & purification</subject><subject>Chlamydia trachomatis - physiology</subject><subject>Chlamydophila pneumoniae</subject><subject>Chlamydophila pneumoniae - isolation & purification</subject><subject>Chlamydophila pneumoniae - physiology</subject><subject>DNA, Bacterial - blood</subject><subject>DNA, Bacterial - cerebrospinal fluid</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoglobulin A - blood</subject><subject>Immunoglobulin A - cerebrospinal fluid</subject><subject>Immunoglobulin G - blood</subject><subject>Immunoglobulin G - cerebrospinal fluid</subject><subject>Immunoglobulin M - blood</subject><subject>Immunoglobulin M - cerebrospinal fluid</subject><subject>Internal Medicine</subject><subject>Laboratory Medicine</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multiple sclerosis</subject><subject>Multiple Sclerosis - blood</subject><subject>Multiple Sclerosis - cerebrospinal fluid</subject><subject>Multiple Sclerosis - microbiology</subject><subject>Multiple Sclerosis - pathology</subject><subject>Pathology</subject><subject>Pneumonia</subject><subject>Severity of Illness Index</subject><issn>0007-4888</issn><issn>1573-8221</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqNkU1rHDEMhk1oaDZpf0AuZSGQ9DKp5c-ZY1j6BSmFfJyN12NnHTzj7XjmkPz6atm0bEoCxQcj6XklpJeQY6DnQKn-VIBK0BUFWXHKdfW4R2YgNa9qxuANmVGEKlHX9QE5LOV-E1IFb8kBU0LVlIkZObvKyc9zmC9WyXYPbbTz2M9_TGmMayxcu-SHXGJ5R_aDTcW_f_qPyO2XzzeLb9Xlz6_fFxeXlcO5Y-Udb51rcBJvGQ8Ulg7nAJNtE4JrZBOUb4Fy22iMteI1SCWVa8QSlLecH5GP277rIf-afBlNF4vzKdne56kY0LVknIEW_4EqAbzhoBA9-Qe9z9PQ4yJIac4kE2KHurPJm9iHPA7WbZqaCyGlwGOzGqnzFyh8re-iy70PEfPPBKc7gpW3aVyVnKYx5r48B2ELOjx5GXww6yF2dngwQM3GcLM13KDhZmO4eUTNh6fNpmXn27-KPw4jwLZAwVJ_54ed1V_t-hvRIrBI</recordid><startdate>20150901</startdate><enddate>20150901</enddate><creator>Ivanova, M. V.</creator><creator>Kolkova, N. I.</creator><creator>Morgunova, E. Yu</creator><creator>Pashko, Yu. P.</creator><creator>Zigangirova, N. A.</creator><creator>Zakharova, M. N.</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7QL</scope><scope>C1K</scope></search><sort><creationdate>20150901</creationdate><title>Role of Chlamydia in Multiple Sclerosis</title><author>Ivanova, M. V. ; Kolkova, N. I. ; Morgunova, E. Yu ; Pashko, Yu. P. ; Zigangirova, N. A. ; Zakharova, M. N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c573t-ec3dcc90003d23f01bc802125d9ffc959f6ed103a97ffc763815656c94b16ea33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Antibodies</topic><topic>Antibodies, Bacterial - blood</topic><topic>Antibodies, Bacterial - cerebrospinal fluid</topic><topic>Bacterial Typing Techniques</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Case-Control Studies</topic><topic>Cell Biology</topic><topic>Chlamydia</topic><topic>Chlamydia infections</topic><topic>Chlamydia Infections - blood</topic><topic>Chlamydia Infections - cerebrospinal fluid</topic><topic>Chlamydia Infections - microbiology</topic><topic>Chlamydia Infections - pathology</topic><topic>Chlamydia trachomatis - isolation & purification</topic><topic>Chlamydia trachomatis - physiology</topic><topic>Chlamydophila pneumoniae</topic><topic>Chlamydophila pneumoniae - isolation & purification</topic><topic>Chlamydophila pneumoniae - physiology</topic><topic>DNA, Bacterial - blood</topic><topic>DNA, Bacterial - cerebrospinal fluid</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoglobulin A - blood</topic><topic>Immunoglobulin A - cerebrospinal fluid</topic><topic>Immunoglobulin G - blood</topic><topic>Immunoglobulin G - cerebrospinal fluid</topic><topic>Immunoglobulin M - blood</topic><topic>Immunoglobulin M - cerebrospinal fluid</topic><topic>Internal Medicine</topic><topic>Laboratory Medicine</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multiple sclerosis</topic><topic>Multiple Sclerosis - blood</topic><topic>Multiple Sclerosis - cerebrospinal fluid</topic><topic>Multiple Sclerosis - microbiology</topic><topic>Multiple Sclerosis - pathology</topic><topic>Pathology</topic><topic>Pneumonia</topic><topic>Severity of Illness Index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ivanova, M. V.</creatorcontrib><creatorcontrib>Kolkova, N. I.</creatorcontrib><creatorcontrib>Morgunova, E. Yu</creatorcontrib><creatorcontrib>Pashko, Yu. P.</creatorcontrib><creatorcontrib>Zigangirova, N. A.</creatorcontrib><creatorcontrib>Zakharova, M. N.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Bulletin of experimental biology and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ivanova, M. V.</au><au>Kolkova, N. I.</au><au>Morgunova, E. Yu</au><au>Pashko, Yu. P.</au><au>Zigangirova, N. A.</au><au>Zakharova, M. N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of Chlamydia in Multiple Sclerosis</atitle><jtitle>Bulletin of experimental biology and medicine</jtitle><stitle>Bull Exp Biol Med</stitle><addtitle>Bull Exp Biol Med</addtitle><date>2015-09-01</date><risdate>2015</risdate><volume>159</volume><issue>5</issue><spage>646</spage><epage>648</epage><pages>646-648</pages><issn>0007-4888</issn><eissn>1573-8221</eissn><coden>BEXBAN</coden><abstract>Chlamydia and antibodies to them were detected by serological, molecular biological, and culture methods in the sera and cerebrospinal fluid of patients with multiple sclerosis and in the reference groups of subjects without neurological diseases. Correlations between the agent presence in the biological fluids of patients and clinical characteristics of the disease were analyzed.
C. pneumoniae
were more incident in the biological liquids of patients with multiple sclerosis than in healthy volunteers. On the other hand, the incidence of the agent in the patients was not high and its presence did not correlate with the clinical manifestations.
C. trachomatis
was equally rare in the patients and volunteers. The studies indicated the existence of a group of patients infected by
C. pneumoniae
in the cohort of patients with multiple sclerosis, but the impact of this agent for the disease course remains unclear.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>26468024</pmid><doi>10.1007/s10517-015-3037-z</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-4888 |
ispartof | Bulletin of experimental biology and medicine, 2015-09, Vol.159 (5), p.646-648 |
issn | 0007-4888 1573-8221 |
language | eng |
recordid | cdi_proquest_miscellaneous_1785232174 |
source | Springer Nature |
subjects | Adult Antibodies Antibodies, Bacterial - blood Antibodies, Bacterial - cerebrospinal fluid Bacterial Typing Techniques Biomedical and Life Sciences Biomedicine Case-Control Studies Cell Biology Chlamydia Chlamydia infections Chlamydia Infections - blood Chlamydia Infections - cerebrospinal fluid Chlamydia Infections - microbiology Chlamydia Infections - pathology Chlamydia trachomatis - isolation & purification Chlamydia trachomatis - physiology Chlamydophila pneumoniae Chlamydophila pneumoniae - isolation & purification Chlamydophila pneumoniae - physiology DNA, Bacterial - blood DNA, Bacterial - cerebrospinal fluid Female Humans Immunoglobulin A - blood Immunoglobulin A - cerebrospinal fluid Immunoglobulin G - blood Immunoglobulin G - cerebrospinal fluid Immunoglobulin M - blood Immunoglobulin M - cerebrospinal fluid Internal Medicine Laboratory Medicine Male Middle Aged Multiple sclerosis Multiple Sclerosis - blood Multiple Sclerosis - cerebrospinal fluid Multiple Sclerosis - microbiology Multiple Sclerosis - pathology Pathology Pneumonia Severity of Illness Index |
title | Role of Chlamydia in Multiple Sclerosis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T03%3A27%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20Chlamydia%20in%20Multiple%20Sclerosis&rft.jtitle=Bulletin%20of%20experimental%20biology%20and%20medicine&rft.au=Ivanova,%20M.%20V.&rft.date=2015-09-01&rft.volume=159&rft.issue=5&rft.spage=646&rft.epage=648&rft.pages=646-648&rft.issn=0007-4888&rft.eissn=1573-8221&rft.coden=BEXBAN&rft_id=info:doi/10.1007/s10517-015-3037-z&rft_dat=%3Cgale_proqu%3EA455405128%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c573t-ec3dcc90003d23f01bc802125d9ffc959f6ed103a97ffc763815656c94b16ea33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1773252446&rft_id=info:pmid/26468024&rft_galeid=A455405128&rfr_iscdi=true |